Security key
23282W605
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 123,724,358
- Total 13F shares
- 140,922,555
- Share change
- +3,340,798
- Total reported value
- $7,744,502,918
- Put/Call ratio
- 22%
- Price per share
- $54.96
- Number of holders
- 379
- Value change
- +$248,284,955
- Number of buys
- 223
- Number of sells
- 127
Report period
Q3 2025
Institutions
379
Top holders
10
CYTK full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
CYTOKINETICS INC SEC filings
CYTOKINETICS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 23282W605
Recent filing periods:
Top shareholders of CYTK - CYTOKINETICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| STATE STREET CORP |
13D/G
13F
|
STATE STREET CORPORATION · Company |
4.7%
|
5,617,334
|
$308,728,677 | $0 | 30 Sep 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
14%
|
17,602,440
|
$581,585,000 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
13%
|
15,677,867
|
$517,996,726 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.7%
|
11,983,838
|
$395,946,007 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
9.1%
|
11,267,511
|
$372,278,580 | — | 30 Jun 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
6.3%
|
7,827,679
|
$258,626,514 | — | 30 Jun 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
3%
|
3,650,000
|
$120,596,000 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
2.5%
|
3,070,665
|
$101,454,772 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
2,994,445
|
$98,948,238 | — | 30 Jun 2025 | |
| Vestal Point Capital, LP |
13F
|
Company |
2.4%
|
2,975,000
|
$98,294,000 | — | 30 Jun 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2.3%
|
2,798,401
|
$92,459,169 | — | 30 Jun 2025 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
2.2%
|
2,721,158
|
$89,907,060 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
2.1%
|
2,645,568
|
$87,409,566 | — | 30 Jun 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.5%
|
1,865,977
|
$61,653,000 | — | 30 Jun 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.2%
|
1,546,391
|
$51,103,093 | — | 30 Jun 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.1%
|
1,385,953
|
$45,791,887 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
1,379,191
|
$45,568,470 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.1%
|
1,357,117
|
$44,839,146 | — | 30 Jun 2025 | |
| Melqart Asset Management (UK) Ltd |
13F
|
Company |
1.1%
|
1,326,719
|
$43,834,796 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.1%
|
1,317,414
|
$43,527,358 | — | 30 Jun 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
1.1%
|
1,312,349
|
$43,360,011 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1%
|
1,298,609
|
$42,906,042 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1%
|
1,273,983
|
$42,092,398 | — | 30 Jun 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.96%
|
1,184,805
|
$39,145,957 | — | 30 Jun 2025 | |
| NORGES BANK |
13F
|
Company |
0.96%
|
1,184,072
|
$39,121,739 | — | 30 Jun 2025 | |
| Capital International Investors |
13F
|
Company |
0.94%
|
1,168,110
|
$38,594,354 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.9%
|
1,118,080
|
$36,941,380 | — | 30 Jun 2025 | |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. |
13F
|
Company |
0.87%
|
1,082,563
|
$35,767,882 | — | 30 Jun 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.87%
|
1,077,000
|
$35,584,080 | — | 30 Jun 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.81%
|
1,000,000
|
$33,040,000 | — | 30 Jun 2025 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.8%
|
995,299
|
$32,884,690 | — | 30 Jun 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.75%
|
922,929
|
$30,493,574 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.71%
|
874,303
|
$28,886,984 | — | 30 Jun 2025 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.59%
|
733,680
|
$24,240,785 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.58%
|
720,814
|
$23,815,695 | — | 30 Jun 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.55%
|
676,280
|
$22,344,000 | — | 30 Jun 2025 | |
| Catalio Capital Management, LP |
13F
|
Company |
0.49%
|
601,439
|
$19,871,545 | — | 30 Jun 2025 | |
| Sarissa Capital Management LP |
13F
|
Company |
0.48%
|
588,357
|
$19,439,315 | — | 30 Jun 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.47%
|
582,147
|
$19,234,137 | — | 30 Jun 2025 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.45%
|
554,731
|
$18,328,312 | — | 30 Jun 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.44%
|
544,292
|
$17,983,408 | — | 30 Jun 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.4%
|
497,602
|
$16,440,770 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.4%
|
492,814
|
$16,282,573 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.37%
|
458,677
|
$15,154,688 | — | 30 Jun 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.35%
|
432,731
|
$14,297,507 | — | 30 Jun 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.34%
|
416,253
|
$13,752,998 | — | 30 Jun 2025 | |
| E. Ohman J:or Asset Management AB |
13F
|
Company |
0.33%
|
407,037
|
$13,448,502 | — | 30 Jun 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.33%
|
402,789
|
$13,308,148 | — | 30 Jun 2025 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
0.32%
|
400,000
|
$13,216,000 | — | 30 Jun 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.32%
|
398,100
|
$13,153,224 | — | 30 Jun 2025 |
Institutional Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q3 2025
As of 30 Sep 2025,
CYTOKINETICS INC - COMMON STOCK (CYTK) was held by
379 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
140,922,555 shares.
The largest 10 holders included
T. Rowe Price Investment Management, Inc., BlackRock, Inc., FMR LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Deep Track Capital, LP, BANK OF AMERICA CORP /DE/, GEODE CAPITAL MANAGEMENT, LLC, and Polar Capital Holdings Plc.
This page lists
380
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
308
Q3 2025 holders
379
Holder diff
71
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.